|
CN110950910A
|
|
Stable minodronic acid compound
|
|
CN110950835A
|
|
Stable lugol pure compounds
|
|
CN110950857A
|
|
Stable lurasidone hydrochloride hydrate compound
|
|
CN110950771A
|
|
Stabilized agomelatine compounds
|
|
CN110950853A
|
|
Engeli hydrate compound
|
|
CN110946832A
|
|
Empagliflozin tablet
|
|
CN110950855A
|
|
Stable iloperidone compound
|
|
CN110946833A
|
|
Acotiamide tablet and preparation method thereof
|
|
CN107569467A
|
|
A kind of capsule preparations of stabilization containing dabigatran etexilate methanesulfonate and preparation method thereof
|
|
CN107778222A
|
|
A kind of exquisite method of roflumilast
|
|
CN107778228A
|
|
A kind of exquisite method of Menglusitena
|
|
CN107782800A
|
|
The method of high-efficient liquid phase chromatogram technique analysis separation support pyrrole department he and its impurity
|
|
CN107778292A
|
|
A kind of his process for purification of support pyrrole department
|
|
CN107782799A
|
|
The method that high-efficient liquid phase chromatogram technique analysis separate asenapine and its intermediate
|
|
CN107778263A
|
|
A kind of preparation method of high-purity Parecoxib Sodium
|
|
CN107778251A
|
|
Flibanserin novel crystal forms
|
|
CN107778296A
|
|
Methanesulfonic acid, which steps, auspicious replaces Buddhist nun's compound
|
|
CN107663213A
|
|
Yi Dushaban trihydrates and its production and use
|
|
CN107663166A
|
|
Lome Tapai and its production and use
|
|
CN107663198A
|
|
Olmesartan medoxomil and its production and use
|
